http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100433609-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 |
| filingDate | 1998-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100433609-B1 |
| titleOfInvention | Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines |
| abstract | The present invention relates to novel benzo [e] isoindole and benzo [h] isoquinoline. Since the compounds according to the invention can bind to serotonin receptors (5HT 2 ), they can cause central nervous disorders (eg depressive disorders, bipolar disorders, anxiety states, sleep and sexual disorders, psychosis, schizophrenia, migraine headaches or other kinds). Other conditions associated with headaches, personal or obsessive compulsive disorder, social phobia or panic attack, mental disorientation, childhood mental disorders, aggression, age-related memory and behavioral disorders, dizziness, obesity, anorexia), trauma, It is particularly suitable for treating or preventing neurological damage, cardiovascular disorders (such as hypertension, thrombosis, seizures, etc.) and gastrointestinal disorders (such as dysfunction of gastrointestinal motility) due to seizures, neurodegenerative disorders, and the like. |
| priorityDate | 1997-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 267.